Novartis buys CoStim Pharmaceuticals
Novartis AG acquired CoStim Phamaceuticals Inc., a closely held firm that has been working on immune-based cancer therapeutics.
- Acquisition of Private Biotech
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.